About APCI

APCI logo

Not a member?
Join today!

(800) 532-2724

Since 1984, APCI has been the ‘united voice of independent pharmacy’

APCI began as a small buying group for a limited number of independent pharmacies in central Alabama. Since that time, the cooperative has grown to more than 1,800 members pharmacies in 26 states, and provides its members with a wide range of products and services.

Our mission is to represent the economic and professional interests of independent pharmacies by providing leadership, vision, and a collective voice for our members in the healthcare marketplace. Our goal is to level the playing field for our member pharmacies by providing innovative, targeted programs to benefit our entire membership.

9

Sep

2016

OptumRx - UnitedHealthcare: New Claims Resolution Process for Therapeutic Dose Limit for Acetaminophen Products - Louisiana Members

Effective October 1st 2016

Effective 10/01/2016, new claims processing functionality will make it quicker and easier for you to resolve Therapeutic Dose Limit (THERDOSE) soft reject edits when dispensing medication for UnitedHealthcare Community Plan in Louisiana members.

THERDOSE screening monitors single ingredient and combination acetaminophen products across multiple claims to determine cumulative daily use. If claims indicate that acetaminophen usage exceeds the U.S. Food and Drug Administration (FDA)-approved maximum daily dose of 4 gm/day, the THERDOSE edit produces a soft reject: Drug Utilization Review (DUR) Reject 88.

Please see attached PDF for more information.

9

Sep

2016

OptumRx - UnitedHealthcare: New Claims Resolution Process for Therapeutic Dose Limit for Acetaminophen Products - Mississippi Members

Effective October 1st 2016

Effective 10/01/2016, new claims processing functionality will make it quicker and easier for you to resolve Therapeutic Dose Limit (THERDOSE) soft reject edits when dispensing medication for UnitedHealthcare Community Plan in Mississippi members.

THERDOSE screening monitors single ingredient and combination acetaminophen products across multiple claims to determine cumulative daily use. If claims indicate that acetaminophen usage exceeds the U.S. Food and Drug Administration (FDA)-approved maximum daily dose of 4 gm/day, the THERDOSE edit produces a soft reject: Drug Utilization Review (DUR) Reject 88.

Please see attached PDF for more information.

9

Sep

2016

CVS Caremark: CareSource - Insect Repellant Covered for State of Ohio Medicaid Members

Effective June 6th 2016

CareSource is an existing client with CVS Caremark®. As previously communicated on August 24, 2016, effective for dates of service on or after June 6, 2016, Ohio Medicaid covers insect repellent in response to the urgent public health issue associated with the Zika virus. Insect repellents that contain DEET or pericaridin are covered for any Medicaid consumer when appropriate to aid in preventing infection with the Zika virus. A prescription for insect repellent from an eligible Medicaid Prescriber is not required for coverage.

8

Sep

2016

Navitus: Texas Medicaid STAR and CHIP Perinate Adult Coverage of Influenza Vaccine for the Fall 2016 Season

Effective September 12th 2016

Effective September 12, 2016, the managed care organizations listed below will cover the influenza vaccine at participating Navitus Texas Network Pharmacies for their members.

Pharmacies participating in the vaccine service network may process the influenza vaccine at the point of service for STAR members ages 18 and older and CHIP Perinate mothers ages 18 and older.

8

Sep

2016

Navitus Pharmacy Newsletter

Fall 2016 - Issue #32

Inside this edition, you will find: 

  • How Do Pharmacies Maintain Compliance with CMS?
  • Formulary Changes

Please see attached PDF for entire newsletter.

First671673Last